Repetitive transcranial magnetic stimulation (rTMS): Use in depression;Repetitive transkranielle magnet-stimulation (rTMS): Anwendung bei depression

Medizinische Monatsschrift fur Pharmazeuten

Volumn 26, Issue 7, 2003, Pages 227-231

  Keck, Martin E ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMETHASONE; DOPAMINE; NORADRENALIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

COGNITION; DEPRESSION; DIAGNOSTIC PROCEDURE; ELECTRICITY; MAGNETIC FIELD; NEUROPSYCHOLOGY; NONHUMAN; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; CLINICAL TRIAL; ELECTROMAGNETIC FIELD; HUMAN; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SYNAPTIC TRANSMISSION;

CLINICAL TRIALS; DEPRESSIVE DISORDER; DOPAMINE; ELECTROMAGNETIC FIELDS; HUMANS; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION; VASOPRESSINS;

EID: 0037477520     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Barker AT, Jalinous R, Freeston IL. Non-invasive stimulation of the human motor cortex. Lancet 1985;1:1106-7.
2. Fibiger HC. Neurobiology of depression: focus on dopamine. Depression and mania 1995;49:1-17.
3. Fleischmann A, Hirschmann S, Dolberg OT, Dannon PN, et al. Chronic treatment with repetitive transcranial magnetic stimulation inhibits seizure induction by electroconvulsive shock in rats. Biol Psychiat 1999;45:759-63.
4. Fleischmann A, Prolov K, Abarbanel J, Belmaker RH. The effect of transcranial magnetic stimulation of rat brain on behavior: models of depression. Brain Res 1995;699:130-2.
5. Groenewegen HJ, Wright CI, Uylings HBM. The anatomical relationship of the prefrontal cortex with limbic structures and the basal ganglia. J Psychopharmacol 1997;11:99-106.
6. Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiat 2000;47:314-24.
7. Höflich G, Kasper S, Hufnagel A, Ruhrmann S, et al. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression - a report of two cases. Hum Psychopharmacol 1993;8:361-5.
8. Holsboer F. Neuroendocrinology of mood disorders. In: Bloom FE, Kupfer DJ (eds.). Psychopharmacology: The fourth generation of progress. New York: Raven Press, 1995:957-68.
9. Ji RR, Schlaepfer TE, Aizenman CD, Epstein CM, et al. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc Natl Acad Sci USA 1998;95:15635-40.
10. Keck ME, Engelmann M, Müller MB, Henniger MSH, et al. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiat Res 2000;34:265-76.
11. Keck ME, Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 2001;22:835-44.
12. Keck ME, Sillaber I, Ebner K, Welt T, et al. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci 2000;12:3713-20.
13. Keck ME, Welt T, Erhardt A, Müller MB, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 2002;43:101-9.
14. Keck ME, Welt T, Post A, Müller MB, et al. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacol 2001;24:337-49.
15. Keck ME, Wigger A, Welt T, Müller MB, et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyperanxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacol 2002;26:94-105.
16. Landgraf R, Wotjak CT, Neumann ID, Engelmann M. Release of vasopressin within the brain contributes to neuroendocrine and behavioral regulation. In: Urban IJA, Burbach JPH, De Wied D (eds). Progress in brain research 119. Amsterdam: Elsevier 1998:201-20.
17. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997;8:523-32.
18. Mikkelsen JD, Woldbye D, Kragh J, Larsen PJ, et al. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and dentate gyrus. Mol Brain Res 1994;23:317-22.
19. Müller MB, Toschi N, Kresse AE, Post A, et al. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacol 2000;23:205-15.
20. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-47.
21. Padberg F, Möller HJ. Repetitive transcranial magnetic stimulation: Does it have potential in the treatment of depression? CNS Drugs 2003;17:383-403.
22. Post A, Keck ME, Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiat Res 2001;35:193-215.
23. Post A, Müller MB, Engelmann M, Keck ME. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur J Neurosci 1999;11:3247-54.
24. Pridmore S. Rapid transcranial magnetic stimulation (rTMS) and normalisation of the dexamethasone suppression test (DST). Psychiat Clin Neuros 1999;53:33-7.
25. Purba JS, Hoogendijk WJG, Hofman MA, Swaab DF. Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiat 1996;53:137-43.
26. Rossini PM, Rossi S. Clinical applications of motor evoked potentials. Electroenc Clin Neurophysiol 1998;106:180-94.
27. Sackeim HA, Prudic J, Devanand DP, Kiersky Y JE, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New Engl J Med 1993;328:839-46.
28. Sackeim HA, Rush AJ, George MS, Marangell LB, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacol 2001;25:713-28.
29. Sesack SR, Pickel VM. Prefrontal cortex efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992;320:145-60.
30. Siebner HR, Rossmeier C, Mentschel C, Peinemann A, et al. Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's disease. J Neurol Sci 2000;178:91-4.
31. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001;21:RC157(1-4).
32. Thomas DN, Nutt DJ, Holman RB. Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmacol 1992;106:430-4.
33. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroenc Clin Neurophysiol 1998;108:1-16.
34. Yoshida K, Higuchi H, Kamata M, Yoshimoto M, et al. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Prog Neuro-Psychopharmacol Biol Psychiat 1997;21:707-15.
35. Zis AP, Nomikos GG, Brown EE, Damsma G, et al. Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacol 1992;7:189-95.